Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MRTX1257
i
Other names:
MRTX1257, MRTX-1257, MRTX 1257
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
BMS
Drug class:
KRAS inhibitor
Related drugs:
‹
AZD4785 (1)
QTX3034 (1)
ATG-012 (0)
ELI-002 7P (0)
KRAS peptide vaccine (0)
SLATE-KRAS (0)
anti-KRAS G12D mTCR PBL (0)
mRNA-5671 (0)
siG12D LODER (0)
AZD4785 (1)
QTX3034 (1)
ATG-012 (0)
ELI-002 7P (0)
KRAS peptide vaccine (0)
SLATE-KRAS (0)
anti-KRAS G12D mTCR PBL (0)
mRNA-5671 (0)
siG12D LODER (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12C
Solid Tumor
KRAS G12C
Solid Tumor
MRTX1257 + IN10018
Sensitive: C3 – Early Trials
MRTX1257 + IN10018
Sensitive
:
C3
MRTX1257 + IN10018
Sensitive: C3 – Early Trials
MRTX1257 + IN10018
Sensitive
:
C3
KRAS G12C
Non Small Cell Lung Cancer
KRAS G12C
Non Small Cell Lung Cancer
selinexor + MRTX1257
Sensitive: D – Preclinical
selinexor + MRTX1257
Sensitive
:
D
selinexor + MRTX1257
Sensitive: D – Preclinical
selinexor + MRTX1257
Sensitive
:
D
KRAS G12C
Pancreatic Ductal Adenocarcinoma
KRAS G12C
Pancreatic Ductal Adenocarcinoma
selinexor + MRTX1257
Sensitive: D – Preclinical
selinexor + MRTX1257
Sensitive
:
D
selinexor + MRTX1257
Sensitive: D – Preclinical
selinexor + MRTX1257
Sensitive
:
D
KRAS G12C
Multiple Myeloma
KRAS G12C
Multiple Myeloma
MRTX1257
Sensitive: D – Preclinical
MRTX1257
Sensitive
:
D
MRTX1257
Sensitive: D – Preclinical
MRTX1257
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login